Bellevue Life Sciences Acquisition Corp. (BLACU) Stock Analysis

What Bellevue Life Sciences Acquisition Corp. does

Bellevue Life Sciences Acquisition Corp. currently lacks substantial active operations. Its principal aim is to pursue and finalize a strategic business combination—such as a merger, share swap, asset purchase, stock acquisition, financial restructuring, or corporate reorganization—with one or more businesses or organizations within the healthcare sector. Established in 2020, the firm maintains its main office in Bellevue, Washington, and functions as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Key metrics

ETFs linked to BLACU

Broad-market and Financial Services sector ETFs an investor holding Bellevue Life Sciences Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BLACU fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Bellevue Life Sciences Acquisition Corp.?

Bellevue Life Sciences Acquisition Corp. trades under the ticker BLACU on NASDAQ.

Which exchange is BLACU listed on?

BLACU is listed on NASDAQ.

What sector does Bellevue Life Sciences Acquisition Corp. operate in?

Bellevue Life Sciences Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze BLACU in a portfolio?

PortView shows BLACU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.